Edesa Biotech, Inc. (EDSA) stock
EDSANasdaqPharmaceutical PreparationsFiscal year ends September 30
$1.96+0.07 (+3.70%)
Close on Nov 17, 2026Market cap $18.90MP/E –Yield –
Edesa Biotech total assets
Total assets on the balance sheet at the end of each period.
Edesa Biotech's total assets was $12.72M at Jun 30, 2026. For fiscal 2025 it was $13.53M, up 254.8% from the year before. Over ten years it grew -0.7% a year on average. The highest annual figure on record is $14.58M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $13.53M | +254.8% |
| FY2024 | Sep 30, 2024 | $3.81M | -57.1% |
| FY2023 | Sep 30, 2023 | $8.89M | -23.2% |
| FY2022 | Sep 30, 2022 | $11.58M | -20.6% |
| FY2021 | Sep 30, 2021 | $14.58M | +35.5% |
| FY2020 | Sep 30, 2020 | $10.76M | +88.2% |
| FY2019 | Sep 30, 2019 | $5.72M | -51.5% |
| FY2018 | Sep 30, 2018 | $11.78M | +52.6% |
| FY2017 | Sep 30, 2017 | $7.72M | -40.3% |
| FY2016 | Sep 30, 2016 | $12.94M | -10.6% |
| FY2014 | Aug 31, 2014 | $14.47M | +70.0% |
| FY2013 | Aug 31, 2013 | $8.51M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $12.72M | -14.1% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $12.38M | -24.7% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $14.71M | +253.3% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $13.53M | +254.8% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $14.80M | +183.2% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $16.45M | +154.1% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $4.16M | -46.8% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $3.81M | -57.1% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $5.23M | -44.5% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $6.48M | -39.3% |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | $7.83M | -32.9% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $8.89M | -23.2% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $9.42M | -46.3% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $10.67M | -47.7% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $11.67M | -5.4% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $11.58M | -20.6% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $17.54M | +3.9% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $20.41M | -15.0% |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $12.34M | +19.9% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $14.58M | +35.5% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $16.88M | +89.1% |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $24.00M | +214.5% |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $10.29M | +102.2% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $10.76M | +88.2% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $8.92M | +23.5% |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | $7.63M | -16.6% |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $5.09M | +49.8% |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $5.72M | -51.5% |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | $7.23M | -43.5% |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | $9.15M | +71.7% |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | $3.40M | -48.5% |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $11.78M | +52.6% |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $12.80M | +41.9% |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | $5.33M | -47.9% |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | $6.59M | -42.5% |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | $7.72M | -40.3% |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $9.02M | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | $10.22M | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | $11.47M | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | $12.94M | – |
See a number that looks wrong?